Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Inhibition of Thromboxane A2-Induced Cl−Secretion by Antidiarrhea Drug Loperamide in Isolated Rat Colon

Tomoyuki Suzuki, Hideki Sakai, Akira Ikari and Noriaki Takeguchi
Journal of Pharmacology and Experimental Therapeutics October 2000, 295 (1) 233-238;
Tomoyuki Suzuki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideki Sakai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Ikari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriaki Takeguchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The antitumor drug irinotecan clinically causes severe diarrhea as a side effect. Thromboxane A2 (TXA2), released by irinotecan, has been shown to be a novel physiological stimulant of Cl− secretion in the rat colon. Herein, we examined the effect of loperamide, an antidiarrhea drug, on Cl−secretion induced by irinotecan; 9,11-epithio-11,12-methano-thromboxane A2(STA2), a stable TXA2 analog; and prostaglandin E2 (PGE2) by using isolated mucosae of the rat colon. In the presence of atropine, loperamide in a concentration-dependent manner inhibited the Cl− secretion induced by irinotecan, STA2, and PGE2. However, the drug inhibited more effectively the irinotecan- and STA2-induced secretion (IC50 = 0.7 and 1.2 μM, respectively) than the PGE2-induced secretion (IC50 = 23 μM). Naloxone, an opiate antagonist, did not affect the antisecretory action of loperamide. Similar to the case for loperamide, W-7, a specific calmodulin antagonist, inhibited more effectively the STA2-induced Cl− secretion (IC50 = 5 μM) than the PGE2-induced secretion (IC50 = 36 μM). W-5, a low-affinity calmodulin antagonist (a dechlorinated control analog of W-7), also inhibited the STA2-induced secretion, but this effect was much less than that of W-7. STA2-induced increase in the intracellular free Ca2+ concentration of single colonic crypt cells was not affected by loperamide. We suggest that loperamide efficiently inhibits the TXA2-induced secretion by blocking the calmodulin system in the colonic epithelium. The present results may explain why coadministration of loperamide with irinotecan is clinically efficient for avoiding the irinotecan-induced side effect of diarrhea.

Footnotes

  • Send reprint requests to: Dr. Hideki Sakai, Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. E-mail: sakaih{at}ms.toyama-mpu.ac.jp

  • ↵1 This work was supported in part by grant-in-aid for Encouragement of Young Scientists from Japan Society for the Promotion of Science (to H.S.), grant-in-aid for Scientific Research (B) from the Ministry of Education, Science, Sports and Culture of Japan (to N.T.), and by grants from Suzuken Memorial Foundation and Takeda Science Foundation (to H.S.).

  • ↵2 These authors contributed equally to this work.

  • ↵3 Present address: Department of Environmental Biochemistry and Toxicology, University of Shizuoka School of Pharmaceutical Science, Shizuoka 422-8002, Japan.

  • Abbreviations:
    TXA2
    thromboxane A2
    U46619
    9,11-dideoxy-9α,11α-methanoepoxy prostaglandin F2α
    STA2
    9,11-epithio-11,12-methano-thromboxane A2
    PGE2
    prostaglandin E2
    Isc
    short-circuit current
    Pd
    potential difference
    Gt
    tissue conductance
    W-7
    N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride
    W-5
    N-(6-aminohexyl)-1-naphthalenesulfonamide hydrochloride
    • Received April 4, 2000.
    • Accepted June 9, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 295 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 295, Issue 1
1 Oct 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Thromboxane A2-Induced Cl−Secretion by Antidiarrhea Drug Loperamide in Isolated Rat Colon
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Inhibition of Thromboxane A2-Induced Cl−Secretion by Antidiarrhea Drug Loperamide in Isolated Rat Colon

Tomoyuki Suzuki, Hideki Sakai, Akira Ikari and Noriaki Takeguchi
Journal of Pharmacology and Experimental Therapeutics October 1, 2000, 295 (1) 233-238;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Inhibition of Thromboxane A2-Induced Cl−Secretion by Antidiarrhea Drug Loperamide in Isolated Rat Colon

Tomoyuki Suzuki, Hideki Sakai, Akira Ikari and Noriaki Takeguchi
Journal of Pharmacology and Experimental Therapeutics October 1, 2000, 295 (1) 233-238;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Increased momentary urethral closure by 5-HT2C agonist
  • Canalicular Transporters Studied with Fluorescent Bile Acids
  • Knockout of Add3 Promotes L-NAME–Induced Renal Injury
Show more Gastrointestinal, Hepatic, Pulmonary, and Renal

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics